All In Biotech

Drug Trial Radar · NCT00540202

Effectiveness of Oral Quinine and Artemether-Lumefantrine in the Treatment of Uncomplicated Malaria in Ugandan Children

Last checked: Nov 20, 2026Latest source record: Oct 5, 2007 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 302 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

302

Planned (sponsor's estimate)

Start

Sep 2007

Primary completion

Not stated

Study completion Apr 2008

Sponsor

Lead sponsor
Makerere UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ministry of Health, Uganda; Uganda Malaria Surveillance Project
First posted
Oct 5, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 months, up to 5 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

We will test the hypothesis that there is a difference in effectiveness of oral quinine in comparison to artemether Lumefantrine in the treatment of uncomplicated malaria in children.

Conditions

  • Uncomplicated Malaria

Interventions

  • artemether-lumefantrineDrug

    Tablets taken twice daily for 3 days according to weight based guidelines.

  • Oral quinineDrug

    Quinine tablets given at 10mg/kg 8 hourly for 7 days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. 1. PCR adjusted parasitological cure rate on day 28. 2. Clinical cure rates on day 28.Time frame: 28 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Mulago National Referral Hospital

    Kampala, Central Region, Uganda · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.